http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6479154-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b55c79232b7a82f550a37f71412452f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-14
filingDate 1987-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3efc4b0352505eebb0acd3c45b7a080
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_714334aee70e483e2088448b8eb11672
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_942905b6524b0c072c1c443311baffd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e3c57254687ae832d4905a46cff828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22a4f34ca1ef4b445341cb69d72fb6bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699e663cb02ff10c4efed7a931327b5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b54b53f3abecb6f0db5113c9e24cec60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db2023f24e25dfff589ffd85ea8bdaff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ed86a1bd1777911c15a338cf73032bc
publicationDate 1989-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6479154-A
titleOfInvention Benzoylurea compound
abstract PURPOSE:To provide a medicinal drug having the form of fine particles with an average particle diameter falling within a specific range, composed of a benzoylurea compound, having excellent carcinostatic activity, high absorbability through digestive tracts and good particle stability in liquid state and administrable without pain and said action of the patient. CONSTITUTION:At least one kind of benzoylurea compound selected from the compound of formula I (X is halogen, nitro or trifluoromethyl; Y is H, halogen, nitro or trifluoromethyl; when Y is nitro, X is halogen or nitro; Z1 is halogen or trifluoromethyl; Z2 is H or halogen; A is =CH- or N) and the compound of formula II (X1 and X2 are H, halogen or nitro; Y is H, halogen, nitro or trifluoromethyl; when Y is nitro, X is H; Z is H, halogen or trifluoromethyl) is crushed in a solution added with a dispersing agent and is used in the form of fine particles having an average particle diameter of <=1mum, especially 0.3-0.8mum.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008231119-A
priorityDate 1986-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6133176-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S611670-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57109721-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0578547-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5799569-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57144259-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6193163-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5615272-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722

Total number of triples: 40.